ALTOS LABS
Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.
ALTOS LABS
Industry:
Biopharma Biotechnology
Founded:
2021-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.altoslabs.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Euro Amazon Google Apps For Business
Current Employees Featured
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Altos Labs
Jeff Bezos
Jeff Bezos investment in Series A - Altos Labs
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-14 | Altos Labs Announces Skip Virgin as Chief Medical Officer and Head of the Altos Institute of Medicine |
Official Site Inspections
http://www.altoslabs.com Semrush global rank: 1.23 M Semrush visits lastest month: 24.76 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Altos Labs"
Altos Labs - About
Altos Labs merges the best of academia and industry to discover and develop medicines that can transform people’s lives. From academia, the freedom to pursue the most challenging …See details»
Altos Labs - Wikipedia
Altos Labs was formally started on 19 January 2022. The name Altos Labs is based on the city of Los Altos in California. The idea for Altos Labs originated with cell biologist and entrepreneur Richard D. Klausner, who co-founded the company with Hans Bishop. In 2021, Altos Labs was registered in the United States and the United Kingdom. It will operate out of California (U.S.) and Cambridge (U.K.), with some work performed in Japan. See details»
Altos Labs - Crunchbase Company Profile & Funding
Contact Email [email protected] Altos Labs is a biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.See details»
Altos Labs - LinkedIn
Altos Labs is a biotechnology company focused on restoring cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life.See details»
Altos Labs launches Institute of Computation
The IoC will also benefit from the expertise of Dr. Thore Graepel, a recognized AI/ML expert who will serve as a Distinguished Fellow across the organization. "We created the Institute of …See details»
Altos Labs Launches with $3B and a Focus on …
Jan 19, 2022 With $3 billion in capital and an executive team to be led by Hal Barron, MD, until now GlaxoSmithKline (GSK)’s President of R&D and Chief Scientific Officer, Altos Labs™ today emerged from ...See details»
Altos Labs launches with the goal to transform medicine through ...
Jan 19, 2022 The Altos executive team will be composed of Hal Barron, MD (incoming CEO), Rick Klausner, MD (Chief Scientist and Founder), Hans Bishop (President and Founder), and …See details»
Altos Labs Company Profile 2024: Valuation, Funding
Altos Labs General Information Description. Operator of a biotechnology company intended to restore cell health and resilience. The company specializes in cellular rejuvenation programming to create a completely new approach to …See details»
Altos Labs launches with the goal to transform …
Jan 19, 2022 A full listing of PIs is found at altoslabs.com. The Altos Board of Directors and advisors include Nobel Laureates and scientific leaders. The Board will be co-chaired by Rick Klausner, ...See details»
Altos Labs launches with the goal to transform …
Jan 19, 2022 Visit www.altoslabs.com to learn more about Altos, including a full list of our senior scientists and leaders. Media Contacts. Morgan Warners Finsbury Glover Hering [email protected] .See details»
Altos Labs - Science
Our mission stems from compelling science. In 2006, Shinya Yamanaka, professor and the director emeritus of Center for iPS Research and Application (CiRA), Kyoto University, and his …See details»
Altos Labs lands $3 billion to further cellular rejuvenation
Aug 21, 2022 A full listing of PIs is found at altoslabs.com. The Altos Board of Directors and advisors include Nobel Laureates and scientific leaders. The Board will be co-chaired by Rick …See details»
Altos Labs launches with $3 billion for cellular rejuvenation
Jan 23, 2022 The biotech company Altos Labs has launched with an unprecedented $3 billion in funding and an equally ambitious goal: using cellular rejuvenation programming to restore cell …See details»
Altos Labs’ Mega-Startup: Wretched Excess Or The Future Of
Mar 9, 2022 The launch of Altos Laboratories with a $3 billion initial commitment—likely the world record startup financing by an order of magnitude or more—says a lot about the state of …See details»
Meet Altos Labs, Silicon Valley’s latest wild bet on living forever
Sep 4, 2021 Among the scientists said to be joining Altos are Juan Carlos Izpisúa Belmonte, a Spanish biologist at the Salk Institute, in La Jolla, California, who has won notoriety for …See details»
Altos Labs
Prior to joining Altos, Dolo was the Senior Vice President of Development Sciences at Denali Therapeutics, where she built and led a translational organization that included Omics, DMPK, …See details»
Altos Labs insists mission is to improve lives not cheat death
Jan 23, 2022 Altos Labs launched with the most funding of any biotech start-up ever, a board packed with Nobel Prize winners — and high expectations that it was trying to defeat death.See details»
Altos Labs Officially Launches with $3 Billion in Funding to Tackle …
Jan 19, 2022 Altos Labs was formed to develop in vivo reprogramming into a viable class of therapies to treat aging. Reprogramming occurs during embryonic development, and the …See details»
Featured - Altos Labs
The big idea here is that a network of Nobel Prize winners and other scientific luminaries allied with some top industry insiders and committed deep-pocket investors can go deep into the …See details»